Yayın: Effect of serotonin 7 receptors and transcript variants on RIN-5F pancreatic beta cell line
| dc.contributor.author | Yayla, Muhammed | |
| dc.contributor.author | Toktay, Erdem | |
| dc.contributor.author | Ozdemir Sarikaya, Bengul | |
| dc.contributor.author | Ermis, Ugur | |
| dc.contributor.author | Akgun, Sakir | |
| dc.contributor.author | Cinar, Irfan | |
| dc.date.accessioned | 2026-01-04T22:02:30Z | |
| dc.date.issued | 2025-06-01 | |
| dc.description.abstract | The physiological effects of 5-HT7 receptors expressed in pancreatic beta cells have not yet been elucidated. We first aimed to investigate the effect of 5-HT7 receptor agonist (AS19) and antagonist (SB269970) application on insulin secretion in RIN-5F pancreatic beta cells. Subsequently, we aimed to investigate the effects of agonist and antagonist applications on cell damage induced by STZ.Cell damage was caused by giving 5 mM STZ solution to the cells for 12 h. The protective effects of 5-HT7 receptor agonist and antagonist on this subsequent damage were investigated. IGF-1, TNF-α, TGF-B1, NF-KB, Bax, Caspase 3, Caspase 9, 5-HT7, 5HT7x2, 5HT7x3 mRNA expression levels were compared between groups.While agonist application stimulates insulin secretion, the effect of the antagonist varies.SB269970 reduced oxidative stress and downregulated TNF-a, TGF-B1 and NF-KB expression and also prevented apoptosis by decreasing Bax, caspase 3 and 9 levels against STZ-induced beta cell damage.The effect of 5-HT7 receptors on insulin secretion and their effects against STZ damage will be guiding for more detailed studies in the treatment of diabetes and related diseases in the future. | |
| dc.description.uri | https://doi.org/10.1016/j.tiv.2025.106050 | |
| dc.description.uri | https://pubmed.ncbi.nlm.nih.gov/40086649 | |
| dc.identifier.doi | 10.1016/j.tiv.2025.106050 | |
| dc.identifier.issn | 0887-2333 | |
| dc.identifier.openaire | doi_dedup___::d0c280d5b6505fcec458f30cb2a2d817 | |
| dc.identifier.pubmed | 40086649 | |
| dc.identifier.scopus | 2-s2.0-86000539118 | |
| dc.identifier.startpage | 106050 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12597/42702 | |
| dc.identifier.volume | 106 | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier BV | |
| dc.relation.ispartof | Toxicology in Vitro | |
| dc.rights | CLOSED | |
| dc.subject | Sulfonamides | |
| dc.subject | Apoptosis | |
| dc.subject | Streptozocin | |
| dc.subject | Rats | |
| dc.subject | Cell Line | |
| dc.subject | Serotonin Receptor Agonists | |
| dc.subject | Oxidative Stress | |
| dc.subject | Insulin-Secreting Cells | |
| dc.subject | Receptors, Serotonin | |
| dc.subject | Insulin Secretion | |
| dc.subject | Animals | |
| dc.subject | Insulin | |
| dc.subject | Serotonin Antagonists | |
| dc.subject | RNA, Messenger | |
| dc.title | Effect of serotonin 7 receptors and transcript variants on RIN-5F pancreatic beta cell line | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.import.source | OpenAire | |
| local.indexed.at | Scopus | |
| local.indexed.at | PubMed |
